Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 24OTHER 9OTHER_GOV 2UNKNOWN 1

Study Type

Interventional 1

Sponsor

Conditions

Esophageal Neoplasms 7Breast Neoplasms 7Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 2Neoplasm Metastasis 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Thymoma 1Thoracic Neoplasms 1Stomach Neoplasms 1Skin Diseases 1Recurrence 1Rectal Neoplasms 1Pain 1Neutropenia 1Neoplasms by Site 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer 1Gastric Adenocarcinoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ductal, Breast 1Carcinoma 1Cancer Pain 1Breast Diseases 1

Interventions

nabiximols 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × UNKNOWN × Cancer Pain × Clear all
NCT01262651 2018-04-23

Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer

GWPharm

Phase 3 Completed
397 enrolled 18 charts

Cancer Pain, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡